Article Versions Notes

Tian T, Zhu Y, Shang K, Shi H, Xu R, Li M, Pu F, Kuang J, Ding J, Zhang F. FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against Brucella. Vaccines. 2025; 13(6):567. https://doi.org/10.3390/vaccines13060567

Tian, Tingting, Yuejie Zhu, Kaiyu Shang, Huidong Shi, Ruixue Xu, Mingzhe Li, Fuling Pu, Junyu Kuang, Jianbing Ding, and Fengbo Zhang. 2025. "FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against Brucella" Vaccines 13, no. 6: 567. https://doi.org/10.3390/vaccines13060567

Tian, T., Zhu, Y., Shang, K., Shi, H., Xu, R., Li, M., Pu, F., Kuang, J., Ding, J., & Zhang, F. (2025). FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against Brucella. Vaccines, 13(6), 567. https://doi.org/10.3390/vaccines13060567